Total Payments
$4,104
2024 Payments
$1,496
Companies
29
Transactions
58
Medicare Patients
148
Medicare Billing
$13,329
Payment Breakdown by Category
Food & Beverage$3,864 (94.2%)
Education$239.94 (5.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,864 | 55 | 94.2% |
| Education | $239.94 | 3 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $436.42 | 6 | $0 (2024) |
| GENZYME CORPORATION | $398.75 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $367.22 | 3 | $0 (2024) |
| BeiGene USA, Inc. | $366.59 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $347.26 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $214.62 | 4 | $0 (2024) |
| Tactile Systems Technology Inc | $205.94 | 2 | $0 (2022) |
| Eisai Inc. | $153.99 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $148.04 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $147.37 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,496 | 35 | Janssen Biotech, Inc. ($347.26) |
| 2023 | $1,260 | 10 | GENZYME CORPORATION ($275.00) |
| 2022 | $972.85 | 10 | Tactile Systems Technology Inc ($205.94) |
| 2021 | $374.98 | 3 | G1 Therapeutics, Inc. ($125.00) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: NONE | ||||||
| 12/11/2024 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $19.21 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.95 | General |
| 11/13/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Oncology | ||||||
| 09/24/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $20.72 | General |
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $27.69 | General |
| 08/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Oncology | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Oncology | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Oncology | ||||||
| 06/21/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 06/19/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 06/10/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: Immunology | ||||||
| 05/23/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: Oncology | ||||||
| 05/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Oncology | ||||||
| 05/14/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $121.13 | General |
| Category: Oncology | ||||||
| 05/07/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2024 | SANOFI-AVENTIS U.S. LLC | SARCLISA (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 67 | 79 | $13,080 | $5,291 |
| 2022 | 2 | 56 | 81 | $11,249 | $5,669 |
| 2020 | 2 | 25 | 30 | $5,264 | $2,369 |
Total Patients
148
Total Services
190
Medicare Billing
$13,329
Procedure Codes
6
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 66 | $11,715 | $4,659 | 39.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 13 | $1,365 | $631.87 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 56 | $8,624 | $4,509 | 52.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 25 | $2,625 | $1,160 | 44.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 19 | $2,800 | $1,304 | 46.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 11 | $2,464 | $1,065 | 43.2% |
About Rian Thornton
Rian Thornton is a Acute Care healthcare provider based in Weaverville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2019. The National Provider Identifier (NPI) number assigned to this provider is 1255975389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rian Thornton has received a total of $4,104 in payments from pharmaceutical and medical device companies, with $1,496 received in 2024. These payments were reported across 58 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,864).
As a Medicare-enrolled provider, Thornton has provided services to 148 Medicare beneficiaries, totaling 190 services with total Medicare billing of $13,329. Data is available for 3 years (2020–2023), covering 6 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Weaverville, NC
- Active Since 11/01/2019
- Last Updated 10/03/2023
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1255975389
Products in Payments
- OPDIVO (Biological) $367.22
- BRUKINSA (Drug) $366.59
- DARZALEX (Biological) $276.01
- IMFINZI (Biological) $272.59
- SARCLISA (Biological) $224.99
- LIBTAYO (Biological) $222.46
- Flexitouch Plus (Device) $165.94
- KEYTRUDA (Biological) $160.85
- Lenvima (Drug) $153.99
- Enhertu (Drug) $148.04
- Lunsumio (Biological) $129.23
- COSELA (Drug) $125.00
- Cabometyx (Drug) $125.00
- LYNPARZA (Drug) $125.00
- MONJUVI (Drug) $124.99
- Orserdu (Drug) $121.11
- ERLEADA (Drug) $71.25
- Padcev (Drug) $47.42
- FLEXITOUCH PLUS (Device) $40.00
- TAGRISSO (Drug) $38.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.